Differences in clinical significance and morphologic features of Blastocystis sp subtype 3

American Journal of Clinical Pathology

Volumn 133, Issue 2, 2010, Pages 251-258

  Vassalos, Constantine M ^a,b   Spanakos, Gregory ^a   Vassalou, Evdokia ^a   Papadopoulou, Chryssanthy ^b   Vakalis, Nicholas ^a  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Amoeboid; Blastocystis sp; Clinical significance; Morphology; Subtype 3

Indexed keywords

METRONIDAZOLE; PROTOZOAL DNA;

ADULT; AGED; ARTICLE; BLASTOCYSTOSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL MORPHOLOGY; PARASITE CULTIVATION; PARASITE ISOLATION; PARASITE VIRULENCE; PRIORITY JOURNAL; BLASTOCYSTIS; CLASSIFICATION; GENETICS; GENOTYPE; INTESTINE INFECTION; ISOLATION AND PURIFICATION; PARASITOLOGY; PATHOLOGY;

ADULT; BLASTOCYSTIS; BLASTOCYSTIS INFECTIONS; DNA, PROTOZOAN; FEMALE; GENOTYPE; HUMANS; INTESTINAL DISEASES, PARASITIC; MALE;

EID: 77449106570     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPDOWQSL6E8DMN     Document Type: Article

References (35)

1. Tan KSW. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev. 2008;21:639-665.
2. Stenzel DJ, Boreham PFL. Blastocystis hominis revisited. Clin Microbiol Rev. 1996;9:563-584.
3. Tan TC, Suresh KG. Predominance of amoeboid forms of Blastocystis hominis in isolates from symptomatic patients. Parasitol Res. 2006;98:189-193.
4. Vdovenko AA. Blastocystis hominis: origin and significance of vacuolar and granular forms. Parasitol Res. 2000;86:8-10.
5. Stensvold CR, Suresh GK, Tan KS, et al. Terminology for Blastocystis subtypes: a consensus. Trends Parasitol. 2007;23:93-96.
6. Stensvold CR, Alfellani MA, Nørkov-Lauritsen S, et al. Subtype distribution of Blastocystis isolates from synanthropic and zoo animals and identification of a new subtype. Int J Parasitol. 2008;39:473-479.
7. Markell EK, Udkow MP. Association of Blastocystis hominis with human disease [letter]? J Clin Microbiol. 1990;28:1085-1086. (Pubitemid 20141236)
8. Zierdt CH. Pathogenicity of Blastocystis hominis [letter]. J Clin Microbiol. 1991;29:662-663.
9. Jones MS, Whipps CM, Ganac RD, et al. Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. Parasitol Res. 2008;104:341-345.
10. Tan TC, Suresh KG, Smith HV. Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential. Parasitol Res. 2008;104:85-93.
11. Boorom KF. Is this recently characterized gastrointestinal pathogen responsible for rising rates of inflammatory bowel diseases (IBD) and IBD associated autism in Europe and the United States in the 1990s? Med Hypotheses. 2007;69:652-659.
12. Boorom KF, Smith HS, Nimri L, et al. Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasit Vectors. 2008;1:40. doi:10.1186/1756-3305-1-40.
13. Spiliopoulou J, Palta M, Nickolas V, et al. Intestinal parasites found in native and foreign workers during a 7-year period in Greece [abstract]. Clin Microbiol Infect. 2004;10(suppl 3):141. Abstract P603.
14. Vassalos CM, Mylona-Petropoulou D, Ganteris G, et al. New trends on Blastocystis sp infection. Acta Microbiol Hel. 2009;54:70-78.
15. Menounos PG, Spanakos G, Tegos N, et al. Direct detection of Blastocystis sp in human faecal samples and subtype assignment using single strand conformational polymorphism and sequencing. Mol Cell Probes. 2008;22:24-29. (Pubitemid 351221239)
16. Robinson GL. The laboratory diagnosis of human parasitic amoebae. Trans R Soc Trop Med Hyg. 1968;62:285-294.
17. Clark CG, Diamond LS. Methods for cultivation of luminal parasitic diarrhea of clinical importance. Clin Microbiol Rev. 2002;15:329-341.
18. Windsor JJ, Macfarlane L. Irritable bowel syndrome: the need to exclude Dientamoeba fragilis [letter]. Am J Trop Med Hyg. 2005;72:501.
19. Vassalos CM, Vakalis N, Papadopoulou C. Blastocystis and its pathogenic potential: latest aspects. Rev Med Microbiol. 2008;19:87-97.
20. Böhm-Gloning B, Knobloch J, Walderich B. Five subgroups of Blastocystis hominis from symptomatic and asymptomatic patients revealed by restriction site analysis of PCR amplified 16S-like rDNA. Trop Med Int Health. 1997;2:771-778. (Pubitemid 27347993)
21. Katsarou-Katsari A, Vassalos CM, Tzanetou K, et al. Acute urticaria associated with amoeboid forms of Blastocystis sp subtype 3 [letter]. Acta Derm Venereol. 2008;88:80-81. (Pubitemid 351212150)
22. Tan TC, Suresh KG. Evidence of plasmotomy in Blastocystis hominis. Parasitol Res. 2007;101:1521-1525.
23. Kaneda Y, Horiki N, Cheng X-J, et al. Serologic response to Blastocystis hominis infection in asymptomatic individuals. Tokai J Exp Clin Med. 2000;25:51-56.
24. Yoshikawa H, Wu Z, Kimata I, et al. Polymerase chain reaction based genotype classification among human Blastocystis hominis populations isolated from different countries. Parasitol Res. 2004;92:22-29. (Pubitemid 38167933)
25. Stensvold CR, Arendrup MC, Jespersgaard C, et al. Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis. 2007;59:303-307. (Pubitemid 350016702)
26. Zierdt CH. Studies of Blastocystis hominis. J Protozool. 1973;20:114-121.
27. Tan TC, Suresh KG. Amoeboid form of Blastocystis hominis: a detailed ultrastructural insight. Parasitol Res. 2006b;99:737-742.
28. Tan TC, Suresh KG, Thong KL, et al. PCR fingerprinting of Blastocystis isolated from symptomatic and asymptomatic human hosts. Parasitol Res. 2006;99:459-465.
29. Souppart L, Sanciu G, Cian A, et al. Molecular epidemiology of human Blastocystis isolates in France. Parasitol Res. 2009;105:413-421.
30. Singh M, Suresh K, Ho LC, et al. Elucidation of the life cycle of the intestinal protozoan Blastocystis hominis. Parasitol Res. 1995;81:446-450.
31. Hussein EM, Hussein AM, Eida MM, et al. Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res. 2008;102:853-860.
32. Puthia MK, Lu J, Tan KSW. Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kappaB-dependent manner. Eukaryot Cell. 2008;7:435-443. (Pubitemid 351959671)
33. Pérez-Brocal V, Clark CG. Analysis of two genomes from the mitochondrion-like organelle of the intestinal parasite Blastocystis: complete sequences, gene content, and genome organization. Mol Biol Evol. 2008;25:2475-2482.
34. Iguchi A, Yoshikawa H, Yamada M, et al. Expression of interferon gamma and proinflammatory cytokines in the cecal mucosa of rats experimentally infected with Blastocystis sp strain RN94-9. Parasitol Res. 2009;105:135-140.
35. Domínguez-Márquez MV, Guna R, Muñoz C, et al. High prevalence of subtype 4 among isolates of Blastocystis hominis from symptomatic patients of a health district of Valencia (Spain). Parasitol Res. 2009;105:949-955. doi:10.1007/s00436-009-1485-y.